Corporation

medicine

Sport Medicine Market Exclusive Profitable Comprehensive Report Cover COVID-19 Updates | Smith & Nephew plc, Stryker Corporation

The MarketWatch News Department was not involved in the creation of this content.

Nov 24, 2020 (WiredRelease via Comtex) —
A consciously conceived and designed business intelligence report titled Global Sport Medicine market 2020 by Manufacturers, Type, and Application, Forecast to 2029 by MarketResearch.biz discloses a succinct analysis of the regional spectrum, market size, and revenue forecast about the market. This report sheds light on the vital developments along with other events happening in the global Sport Medicine market which is marking on the enlargement and opening doors for outlook growth in the coming years.

This is the latest report, covering the current COVID-19/Corona Virus pandemic impact on the market which has affected every aspect of life globally. This has brought along several changes in market conditions and the Business areas. The rapidly changing market scenario and initial and future assessment of the impact are covered in the Sport Medicine market report.

For All-Inclusive Information: Download a FREE sample copy of Sport Medicine Market Report Study 2020-2029 at https://marketresearch.biz/report/sport-medicine-market/request-sample

(Our FREE SAMPLE COPY of the report gives a brief introduction to the research report outlook, list of tables and figures, Impact Analysis of COVID-19, TOC, an outlook to key players of the market and comprising key regions.)

Competitive Analysis:

The major companies are exceedingly focused on innovation in Sport Medicine production technology to enhance ledge life and efficiency. The best long-term development path for Sport Medicine market can be caught by guaranteeing financial pliancy to invest in the optimal strategies and current process improvement.

Key manufacturers are included based on the company profile, sales data and product specifications, etc: Smith & Nephew plc, Stryker Corporation, Johnson & Johnson Private Limited, Arthrex Inc., Conmed Corporation, Zimmer Biomet Holdings, Inc., Breg, Inc., Mueller Sports Medicine, Inc., DJO Global, Inc., Wright, Medical Group N.V.

Each manufacturer or Sport Medicine market player’s growth rate, gross profit margin, and revenue figures is provided in a tabular, simple format for few years and an individual section on Sport Medicine market recent development such as collaboration, mergers, acquisition, and any new service or new product launching in the market is offered.

Sport Medicine Market Segmentation Outlook By product, application, and region:

Global sport medicine market segmentation, by product:
Body Reconstruction and Repair Products
Body Support and Recovery Product
Body Monitoring and Evaluation
Accessories

Global sport medicine market segmentation, by application:
Knee Injuries
Hip Injuries
Shoulder Injuries
Ankle & Foot Injuries
Back & Spine Injuries
Elbow & Wrist Injuries
Other Injuries

Download Now And Browse Complete Information On The COVID 19 Impact Analysis On Sport Medicine Market: https://marketresearch.biz/report/sport-medicine-market/covid-19-impact

Regional Analysis:On the idea of geography, the Sport Medicine Market report covers statistics for a couple of geographies inclusive of, North America (U.S., Mexico, Canada) South America (Argentina, Brazil) The Middle East & Africa (South Africa, Saudi Arabia) Asia-Pacific (China, Japan, India, Southeast Asia) Europe (U.K., Spain, Italy, Germany, France, Russia)

In addition, The following years considered for this study to forecast the global Sport Medicine market size are

Read More
medicine

Sports Medicine Market 2020 Analysis – Stryker, CONMED Corporation, Johnson & Johnson Services, Bird & Cronin

The MarketWatch News Department was not involved in the creation of this content.

Nov 06, 2020 (CDN Newswire via Comtex) —
Global Sports Medicine Market is expected to rise from its initial estimated value of USD 19.45 billion in 2018 to an estimated value of USD 37.35 billion by 2026, registering a CAGR of 8.5% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing incidences of sports injuries.

Global Sports Medicine Market research report showcases thorough insights about the Orthopedic Devices industry which are based on business intelligence. To bring about a supreme expertise of the best market opportunities into their applicable markets, businesses can take up this market report. The market report offers market potential for each geological region based on the growth rate, macroeconomic parameters, consumer buying patterns, their inclinations for particular product and market demand and supply scenarios.

Download exclusive PDF sample report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-sports-medicine-market

Global Sports Medicine Market By Product Type (Orthobiologics (Bone Graft Substitutes, Viscosupplementation, BMC, PRP), Surgical Devices (Plates and Screws), Arthroscopy Devices, Orthopedic Braces and Supports), Body Area (Knee, Hip, Shoulder & Elbow, Foot & Ankle, Wrist & Hand), Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Elbow and Wrist Injuries, Back and Spine Injuries, Hip and Groin Injuries), End Users (Orthopedic Clinics, Hospitals, Ambulatory Surgical Centers, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Few of the major competitors currently working in the sports medicine market are

Arthrex, Inc. (Germany),

Smith & Nephew (UK),

DePuy Synthes (US),

Stryker (US),

CONMED Corporation (US),

Johnson & Johnson Services (US),

Bird & Cronin (USA),

Zimmer Biomet (US),

Anika Therapeutics, Inc. (US),

Ossur (Europe),

Breg, Inc. (US),

Mueller Sports Medicine, Inc. (US),

DJO Global, Inc. (US),

Medtronic (Ireland),

GENERAL ELECTRIC (US),

Ceterix Orthopaedics (USA),

KFx Medical LLC. (US),

MedShape, Inc. (USA),

NuVasive, Inc. (US),

Flexion Therapeutics Inc. (US)

Market Definition: Global Sports Medicine Market

Sport Medicines can be defined as a medical branch which is deals with diagnosis, treatment and prevention of the injuries or illness of athletics or sportsman. Sports medicines play an initial and important part in the sports.

According to US centers for diseases control, around 10 % of kids and teen participating in the sports suffer include minor or major type of injury and majority of the sports injury occur during 12-16 yr of age. Sports like Football and baseball has the highest rate of injury. Beside this lack of safety and carelessness during practice or game is the major reason for occurrence of the sports injuries.

Market Drivers

  • Increasing adoption of arthroscopic surgeries, this act as driver to the market.
  • Continuous influx of new products and treatment modalities, this act as driver to the market.

Market Restraints

  • Unfavorable reimbursement strategies, this significant act as market restraints.
  • Inappropriate administration and guidelines pertaining to sports medicine, this significant act as market restraints.

Key Developments in the Market:

  • In November 2018, Colfax Corporation announced
Read More
health

Quidel Corporation Joins Global Lyme Alliance as Sponsor for the GLA ‘Fight Lyme With Avril Lavigne and Friends’ Virtual Concert Oct. 24

As part of its commitment to help educate Americans on the perils of Lyme disease, Quidel Corporation announced today that it will be one of the sponsors of the inaugural Global Lyme Alliance (GLA) “#FightLyme With Avril Lavigne & Friends” concert being held on Oct. 24. Quidel is the diagnostic health care manufacturer behind the industry’s most rapid and reliable in-office test for Lyme disease, the Sofia 2 Lyme FIA test.

“The Global Lyme Alliance has been a passionate and important partner for Quidel in our fight against Lyme disease,” said Judi Tilghman, Ph.D., vice president of technology assessment at Quidel. “Over the years they have helped fund the most urgent and promising research in the field, while expanding education and awareness programs for the general public and physicians. We’re honored to be their partner for this wonderful upcoming event.”

Being held in lieu of its annual gala, GLA will be presenting the inaugural #FightLyme With Avril & Friends virtual concert featuring Avril Lavigne, Rob Thomas, OneRepublic, Alessia Cara and host Wilmer Valderrama. The concert is designed to raise awareness and funds for GLA and The Avril Lavigne Foundation in support of their fight to conquer Lyme disease and other tick-borne diseases through research, education, awareness and patient services. Both Lavigne and Thomas have experienced Lyme disease on a personal level, and Lavigne is also a GLA board member who has been extremely vocal about the fight against Lyme disease.

The Oct. 24 concert will begin at 8 p.m. Eastern Time. Tickets can be purchased and more information is available at https://tinyurl.com/y54dn89a. More information on the Global Lyme Alliance can be found at GLA.org.

Lyme disease afflicts as many as 400,000 Americans every year and can lead to a number of serious, life-threatening problems if not caught early. Leading the way in Lyme disease testing is Quidel’s innovative Sofia® 2 Lyme FIA test. This test provides a patient as well as his or her physician with indicative results within minutes as opposed to days, which has historically been the norm. Performed in the privacy of a doctor’s office or local clinic, it is also the only test that can get results from a simple finger prick of blood. Given that the vast majority of patients tested are negative, not having to wait days for test results allows physicians and nurse practitioners to more rapidly treat those patients with positive results while more quickly pursuing other diagnosis and treatment for those who test negative.

About Quidel Corporation

Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of diagnostic solutions at the point of care delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive

Read More